Russian envoy to India Denis Alipov suggested on Friday that Indian pharmaceutical companies may replace Western producers leaving the Russian market.
“In several areas, including medicines, the withdrawal of numerous Western corporations from the Russian market and the niches that have been deserted may actually be occupied by Indian enterprises,” Alipov stated in a recent interview with a Russian news channel.
India, according to the recently appointed Russian envoy, is a “global pharmacy” and a top creator of medication duplicates that are as good as the original.
Last year, India’s Vaccine Maitri project solidified its position as the world’s “pharmacy.” At important junctures in the pandemic, world leaders publicly praised India’s efforts to swiftly expand vaccine production and supplies.
This plan to change manufacturers in the pharmaceutical sector comes at a time when Russia is being targeted by Western countries with sanctions. Russia is currently aiming to expand its economic ties with non-European nations. Earlier this month, Alipov had said that Moscow has hailed India’s independent foreign policy amid the Russia-Ukraine conflict.
According to the envoy, Russia’s relations with India are based on the consistent, independent policy of the state in international affairs, which PM Modi and the Indian leadership meet. We have repeatedly pointed out how we welcome and support India’s independent foreign policy.
Read Also: Pharma Stocks Gain, Market Ends Marginally Lower At 90 Points
